Insys Therapeutics Inc. (Nasdaq: INSY) warned that first quarter revenue would miss expectations sending the stock price plummeting $3.42 to close at $14.24.
Insys Therapeutics warns of shortfall
April 11, 2016 at 17:27 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.